is there an age limit for glp-1 How young too young GLP-1s? Bariatric surgery? Academic experts offer insights Age and GLP-1 Medications: Clinical

The market growth is driven by the increasing prevalence of type 2 diabetes and obesity, the rising aging population and lifestyle changes, and the ongoing development of new drug formulations

62 A controlled clinical trial conducted in Israel and published in 2002 enrolled 133 participants with unexplained sudden hearing loss

Regulatory and Market Dynamics: Regulatory approvals and market competition influence the availability and pricing of these therapies

Therefore, this review aims to summarize current research progress on ferroptosis and its pivotal role in CKD, providing insights for subsequent studies to establish ferroptosis as a therapeutic target for CKD